AMY WEAVER: Open Payments
NPI 1891715025 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$779 in 36 payments from 19 companies in 2025. Trend: 2023 $1,227 · 2024 $674 · 2025 $779
Food & beverage: $779
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $184 |
| Echosens North America, Inc. | 1 | $80 |
| ABIOMED | 2 | $75 |
| Exact Sciences Corporation | 3 | $56 |
| Abbott Laboratories | 2 | $47 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $47 |
| Novo Nordisk Inc | 2 | $44 |
| Viatris Specialty LLC | 1 | $34 |
| Teleflex LLC | 1 | $33 |
| Edwards Lifesciences Corporation | 1 | $24 |
Products named: VRAYLAR, Fibroscan, FREESTYLE LIBRE 3, XIFAXAN, Rybelsus, YUPELRI, TURNPIKE, SAPIEN 3 Ultra RESILIA.
Industry payments across TX — which companies pay providers there.
